Microbix Biosystems (TSE:MBX) Sets New 12-Month High – Should You Buy?

Microbix Biosystems Inc. (TSE:MBX)’s share price hit a new 52-week high during trading on Wednesday . The company traded as high as C$0.50 and last traded at C$0.50, with a volume of 1457199 shares trading hands. The stock had previously closed at C$0.44.

Microbix Biosystems Trading Down 2.0 %

The business has a 50 day moving average of C$0.38 and a two-hundred day moving average of C$0.35. The firm has a market capitalization of C$66.98 million, a price-to-earnings ratio of 12.25 and a beta of 0.34. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62.

Insider Transactions at Microbix Biosystems

In other Microbix Biosystems news, Director Cameron Lionel Groome sold 200,000 shares of Microbix Biosystems stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of C$0.43, for a total transaction of C$86,500.00. 14.00% of the stock is owned by insiders.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.